Paraspinous Anesthetic Block for Non-Responsive Pelvic Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01635205|
Recruitment Status : Completed
First Posted : July 9, 2012
Last Update Posted : April 24, 2014
|Condition or disease||Intervention/treatment||Phase|
|Paraspinous Block Pelvis Pain Chronic||Procedure: paraspinous anesthetic block Procedure: subcutaneous puncture with no anesthetic effect||Phase 4|
Patients will be allocated into one of two groups (intervention or placebo), and will be submitted to the corresponding procedure (paraspinous anesthetic block or placebo puncture in subcutaneous tissue). In the first appointment, pain will be measured with the VAS (Visual Analogue Scale); quality of life and function basal level will be evaluated by scales SF-36 (Medical Outcome Short-Form (36)Health Survey)and FSFI (Female Sexual Function Index), in Portuguese validated versions. Procedure will be realized as planned for each group.
Second appointment will occur one week after the procedure, and VAS scale will be applied.
Third appointment will occur in one month. VAS scale will be applied again,and procedure will be repeated if patient does not have a reduction of at least 30% of pain.
Next consultations will occur at two months, three months, four months and five months, with application of VAS scale to keep monitoring evolution of pain.
At six months of study, VAS scale will be applied along with SF-36 and FSFI questionnaires, to evaluate improvement in pain and in quality of life and function level.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Efficacy of Paraspinous Anesthetic Block in Patients With Chronic Pelvic Pain Non-Responsive to Pharmacological Treatment|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||May 2013|
|Actual Study Completion Date :||May 2013|
Experimental: paraspinous block
Paraspinous anesthetic block in the thoracolumbar region, in sensitized segments
Procedure: paraspinous anesthetic block
Paraspinous anesthetic block with lidocaine 1% in sensitized segments of the thoracolumbar region
Sham Comparator: control
Subcutaneous puncture with no anesthetic effect
Procedure: subcutaneous puncture with no anesthetic effect
Subcutaneous puncture with injection needle (no substance will be injected)
- Change of pain from baseline [ Time Frame: Change of pain from baseline at one week, at one month, at two months, at three months, at four months, at five months and at six months ]Primary outcome is the reduction of pain, measured with the Visual Analogue Scale (VAS).
- Improvement of scores in SF-36 scale [ Time Frame: At baseline and at six months ]Quality of life will be evaluated with SF-36 scale at baseline and at six months, and scores will be compared at the end of the study.
- Improvement of scores in the FSFI scale [ Time Frame: At baseline and at six months ]Sexual function as a measure of functionality will be evalueted with the FSFI scale at baseline and at six months, and scores will be compared at the end of the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01635205
|Hospital de Clínicas de Porto Alegre|
|Porto Alegre, Rio Grande do Sul, Brazil|
|Principal Investigator:||Karen F Rosa, MD||Hospital de Clínicas de Porto Alegre|
|Study Chair:||Antonio C Santos, doctor||Hospital de Clínicas de Porto Alegre|
|Study Chair:||Ricardo F Savaris, doctor||Hospital de Clínicas de Porto Alegre|
|Study Chair:||Vinícius A Amantéa, MD||Hospital de Clínicas de Porto Alegre|